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Abstract
EEC (ectrodactyly, ectodermal dysplasia, clefting; OMIM 604292) is an autosomal dominant developmental disorder
resulting mainly from pathogenic mutations of the DNA-binding domain (DBD) of the TP63 gene. In this study, we showed
that K193E mutation in nine affected individuals of a four-generation kindred with a large degree of phenotypic variability
causes four different syndromes or TP63-related disorders: EEC, Ectrodactyly-ectodermal dysplasia (EE), isolated ectodermal
dysplasia, and isolated Split Hand/Foot Malformation type 4 (SHFM4). Genotype-phenotype and DBD structural modeling
analysis showed that the K193-located loop L2-A is associated with R280 through hydrogen bonding interactions, while
R280 mutations also often cause large phenotypic variability of EEC and SHFM4. Thus, we speculate that K193 and several
other DBD mutation-associated syndromes may share similar pathogenic mechanisms, particularly in the case of the same
mutation with different phenotypes. Our study and others also suggest that the phenotypic variability of EEC is attributed,
at least partially, to genetic and/or epigenetic modifiers.
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Introduction
The TP63 gene encodes the tumor suppressor p63 with six
isoforms that are involved in limb, epithelial, and craniofacial
development. Heterozygous mutations of the TP63 gene have
been found to be responsible for at least five rare syndromic and
two non-syndromic human disorders [1–6]. The full-length p63
consists of six domains: 1) the transactivation (TA) domain, 2) the
DNA binding domain (DBD), 3) the tetramerization (ISO)
domain, 4) the second transactivation domain (TA2) domain, 5)
the sterile-a-motif (SAM), and 6) the transactivation inhibitory
domain (TID). The DBD is present in all splicing isoforms of
p63, but its mutations result in multiple syndromes, such as the
most prevalent ectrodactyly-ectodermal dysplasia-clefting syn-
drome (EEC), the ectrodactyly-ectodermal dysplasia syndrome
(EE), the isolated Ectodermal dysplasia, and the isolated split
hand/foot malformation type 4 (SHFM4) [2,7]. The main
difference between EEC and SHFM4 is that three major
symptoms (split-hand/foot, ectodermal dysplasia, and cleft lip/
palate) are observed in EEC patients [8], whereas only limb
malformations (split-hand/foot) are found in SHFM4 patients
[9,10]. However, whether the genotype–phenotype correlation of
these two disorders is associated with the structure and function
of DBD remains unclear.
In recent crystal structure analysis of p63 DBD, of 22 p63 DBD
mutated positions, four are expected to impair DNA binding, 16
are expected to reduce protein stability, while others are thought
to indirectly impact DNA binding, zinc binding, or tetrameriza-
tion [11]. However, it is still unclear whether the different
phenotypes between EEC and SHFM4 are associated with the p63
DBD mutations in different positions or are simply due to different
genetic modifiers that result in wide phenotypic variability.
In this study, we describe a wide phenotypic spectrum featured
in EEC, EE, isolated Ectodermal dysplasia, and also SHFM4
observed from a Chinese family. Phenotypic variations and
structural models of p63 DBD with several specific mutations
are also discussed.
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Phenotypic Variability in the Affected Family Members
Clinical analysis revealed that ectrodactyly and syndactyly in
hands and/or feet were present in almost all affected individuals
with the exception of patient II-3 who showed an isolated
ectodermal dysplasia. Three types of hands/feet malformation
were found in these patients: 1) Symmetrical Split hand-Split foot
malformation (shown in patient IV-3, Figure 1; patient III-5,
Figure 2A; patient II-9, Figure S1A; patient III-3, Figure S1B; and
patient IV-4, Figure S1C). 2) Asymmetric Split hand-Split foot
(shown in patient III-7, Figure 2B). 3) Minor abnormalities (or
none at all) in hands or feet (shown in patient II-3, Figure 2C;
patient I-2, Figure S1D; and patient IV-2, Figure S1E). In
addition, patient IV-2 showed syndactyly on her right foot, but
had totally normal hands and left foot. Interestingly, patient II-3
appeared to have hearing impairment and mild mental retarda-
tion; but no deformities were found in her hands or feet
(Figure 2C). Both of her daughters (III-3 and III-5) had
symmetrical hands/feet abnormalities.
Overall, the main deformities related to the ectodermal
development in this family includes split hands/feet (8/9) and
several other ectodermal developmental dysplasia, such as
hypopigmented and sparse hair (6/8), sparse eyebrows (6/8),
and ocular hypertelorism (2/8) (Table S2). Central nervous system
(CNS) defects such as mild mental retardation (3/7) and hearing
impairment with or without speech impairment (2/8) were also
observed (Table S2). Interestingly, the CNS defects were the main
clinical manifestation for patient II-3, while she did not show any
limb defect. No family members showed any significant abnor-
malities in skin, eyes, mouth, nose, nipples, or exocrine glands (for
sweat), lacrimal, and salivary secretion. Nail deformity was shown
in the patient II-9, but not present in other family members. Table
S2 also listed several alterations related to oral-craniofacial
development, including micrognathia (1/9), bilateral cleft lip-
palate (1/9), malformed teeth (3/8), and hypodontia (4/8)
(Figure 2). Taken together, typical EEC phenotypes were observed
in patient IV-3, EE phenotypes in II-9, III-3, III-5, and IV-2,
possible isolated SHFM4 phenotypes in I-2, III-7, and IV-4, and
isolated Ectodermal dysplasia in II-3 (Table S2).
Mutation Analysis
PCR products of the TP63 gene were bidirectionally sequenced
from two affected individuals (III-5 and IV-3). A heterozygous
missense mutation 577ARG in exon 5 was detected, which
predicts amino acid substitution p. K193E (TA p63 alpha isoform,
GenBank acc. no., AF075430) (Figures 3A and 3B). Further
analysis of this exon for the family confirmed the K193E mutation
present in all patients examined, but not in unaffected individuals.
In order to exclude the possibility of a rare single nucleotide
polymorphism (SNP) in the Han population, 50 normal unrelated
individuals were sequenced and no mutations were found.
Multiple sequence alignment showed that K193 in the p63 DBD
is evolutionarily conserved from zebrafish to humans (Figure 3C).
Location of Mutated Residues in 3D Structure
Crystal structural analysis of p63 DBD suggests that most EEC
mutations that cause developmental defects either reduce the
protein stability or affect DNA binding ability [11]. In the
monomer of p63 DBD, K193 is on the loop L2-A (Figure 3D);
while when the DBD is in the complex with target elements of
DNA, K193 is on the outer surface and the dimer-dimer interface
of type II tetramer (Figure 3E). K193 mutation may thus affect
p63 association with other proteins and the dimer-dimer stability,
but not the DNA binding [11].
Since K193E mutation was previously identified in a male fetus
whose father showed isolated split-hand/foot (SHFM4) pheno-
types [12] and was claimed as a SHFM4-specific mutation, we
thus position all other SHFM4-associated residues in 3D structures
for a potential correlation analysis. In Figure S2A, K194 is
expected to be located next to K193 on the loop L2-A; R280 is
also associated with the L2-A loop, unexpectedly, by hydrogen
bonding interaction with E200, while K193 is associated with S10
region via hydrogen bonding interaction with E302. These
interactions suggest that the mutations (K193E, K194E, and
R280H/C/S) might affect protein-protein interactions via the L2-
A loop-containing region. However, positions of T154–Y155 and
G310 are found to be associated with DNA-binding. Therefore,
these two mutations (proline insertion between residue T154–
Y155 and G310E) are expected to affect DNA affinity directly
(Figure S2B). Whether these mutations affect protein interactions
or DNA affinity needs further investigation.
Discussion
Review of the previously reported EEC patients [13–17] and
SHFM4 patients with six different DBD mutations [2,13,18],
including K193E [19], K194E [7,19,20], R280C, R280H (but not
R280/S that causes EEC) [7,19,21,22], G310E [23], the proline
insertion between T154–Y155 [19], and patients in this study,
revealed a wide phenotypic spectrum of the TP63 gene mutations.
The fact that different patients of this family, who carried the same
mutation, showed a substantial degree of clinical variability
indicates that K193E is a common EEC mutation, rather than a
SHFM4-specific one as previously claimed.
It was observed that K193 was a potential SUMO-1 target [24]
and K193E was less sensitive to Itch (E3-ubiquitin ligase)-mediated
p63 degradation [25]. However, a recent study demonstrated that
Itch directly binds the PY motif of p63 SAM domain rather than
the DBD domain [26]. Since K193 is on the surface of DBD, it
may interact with other proteins and is involved in the stability of
the p63 tetramer. In addition, the mutant K193E may have
dominant-negative effects and thus compromise the function of the
wild-type allele of p63. How the expression level and stability of
p63 are affected by K193E in our patients needs to be further
studied to be confirmed.
During the course of our investigation, we found that four
SHFM4 mutations (K193E; K194E, R280C, and R280H) are
associated with the L2-A loop of p63 BDB and two SHFM4
mutations (proline insertion and G310E) are affecting DNA
binding. However, six EEC mutations (Y192C/D, V202M, and
R204L/Q/W) are also found on the L2-A loop (residue 192 to
205) and additional nine EEC mutations (S272N, R279C/H/Q,
R304P/Q/W, and C308S/Y) are expected to impair DNA
binding [9,11]. Moreover, even the same residue mutations
(K193E and R280C/H/S) are found to cause either EEC or
SHFM or both. We speculate that global DBD structure and
stability are expected to be affected by mutations of different
residues that are tightly connected by side chains such as the L2-A
loop. Therefore, the associated structural locations and functions,
as well as the overlapping phenotypic spectrum, indicate that EEC
and SHFM4 might be caused by similar pathogenic mechanisms.
Further experimental p63 structure analyses via mutagenesis and
functional tests are required to testify this hypothesis.
Although the causes of the wide intrafamilial and interfamilial
phenotypic variability remain unclear, we agree that one of them
could be the result of modifier genes and/or genetic background
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different phenotypes [e.g., R280C/H found in either EEC [21] or
SHFM4 [7], R280S only found in EEC [19]]. What determines the
different phenotypic expressions (EEC vs. SHFM) of the R280C/
H/S or K193E mutation in different families or even in the same
family? The influence of genetic and/or environmental modifiers
has been suggested to explain the variable clinical expressivity [27].
LinkageanalysisofanEECfamilywithR280Chasidentifiedatleast
two modifier genes for clefting phenotype on chromosomes 4q and
14 [21]. The Orofacial Cleft 4, which was mapped to the same
regionon4q21–31[28],couldbeoneofthecandidates.Also,lossof
thep63bindingsite,whichisrequiredfortheexpressionofthedistal-
less homeobox 6 gene (DLX6) located in the SHFM1 locus on
chromosome 7q, was recently identified in a patient with SHFM
phenotype [29]. Therefore, the different clinical conditions exhib-
ited in EEC/SHFM4 patients suggest that additional minor
modifying genes that predispose to non-syndromic cleft lip/palate
and other tissues/organs could presumably contribute to the
expressivity of the equivalent phenotypes in different patients. On
the other hand, hundreds of targets of p63 were identified by ChIP
on chip analysis in human keratinocytes, including many critical
transcriptionalfactors, suchasNotch,TGFband WNTsignalingin
developmental pathways [30,31]. As expected, a homozygous
mutation of the WNT10b gene was recently identified as a new
causative gene for SHFM [32]. These results suggest that genetic
modifiers that participate or overlap the same signaling pathway in
Figure 1. The pedigree of the family and clinical feature of the proband. Upper panel: Filled symbols represent the affected individuals. The
proband is indicated by an arrow. Males are represented by squares, females by circles. A slashed circle indicates a deceased subject. The person
whose DNA sample is available for sequencing is marked by ‘‘*’’. For simplicity, spouses and children of normal siblings in generation II and III are not
shown. Lower panel: Clinical feature of the proband. (A) Thinning of hair on the scalp and lateral eyebrows, ocular hypertelorism, and cleft lip. (B) Cleft
palate. (C) Syndactyly and ectrodactyly of the hands. (D) Radiography of the hands. (E) Malformation of the feet. (F) Radiography of the feet. (G & H)
CT scanning and reconstruction of the head and craniofacial bones.
doi:10.1371/journal.pone.0035337.g001
K193E Mutation of the TP63 Gene
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e35337Figure 2. Three types of hands/feet manifestations and malformed teeth. (A) Symmetrical deformities. Patient III-5: absence of 2nd–3rd
fingers and 2nd–3rd toes. Hand radiography: absence of 2nd–3rd phalanges and fusions of the 1st–2nd and 3rd–4th metacarpale in both hands. Feet
radiography: absence of 2nd–3rd phalanx and osseous fusion of 1st–2nd metatarsal bone. Left panel: spade-shaped central incisor and open bite. (B)
Asymmetric deformities. Patient III-7: Syndactyly of 1st–2nd finger, absence of middle finger, syndactyly of 1st–2nd and 3rd–4th toes. Radiography:
missing third phalanges and cutaneous syndactyly of 1st–2nd and 3rd–4th toes. Left panel: cone-shaped left maxillary lateral incisor. (C) Patient II-3:
Hands or feet were undistinguished from normal controls. (D) Patient III-3: Absent right maxillary lateral incisor and malformed lingual fossa in the left
maxillary lateral incisor.
doi:10.1371/journal.pone.0035337.g002
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reducethephenotypesresultingfromthedysfunctionalp63.Further
studies using SNP genome screening in large kindreds may identify
modifying genes that influence variable expressivity of monogenic
disorders.
Materials and Methods
Patients
Nine affected individuals from a four-generation family with
autosomal dominant inherited patterns (located in Zhen’an county
of Shaanxi province in Northwest China) were examined (Figure 1,
upper panel). General information of the patients is provided in the
Table S1. DNAs were extracted (QIAamp DNA blood kit, Qiagen,
Chatsworth, CA, USA) from peripheral blood samples of available
patients, normal members of this family, and 50 unrelated normal
controls. The study was approved by the Ethics Committee, School
of Stomatology of the Fourth Military Medical University. Written
informed consents were obtained from each subject. Parents or
guardians consented on the behalf of the patients who were under
18 year-old (IV-2, IV-3, and IV-4) or who had a reduced capacity/
ability to consent (II-3, II-9, and III-5).
The proband is a 2.5-year-old boy who was presented with a
bilateral cleft lip and palate, hypopigmented and sparse hair, and
ocular hypertelorism (Figures 1A and 1B). He had syndactyly and
ectrodactyly of both hands and feet. His right index and both
middle fingers were absent while the 1st–2nd and 3th–4th fingers
of both hands showed syndactyly (Figure 1C). Radiography
showed aplasia in the 2nd metacarpale, 2nd–3rd phalanges to the
right hand, and syndactyly on the 1st–2nd and 3rd–4th phalanges
to his left hand (Figure 1D). Both of his 2nd toes were ectrodactyly,
while the 3th–4th toes were syndactyly (Figure 1E). Radiographic
analysis showed the absent of the 2nd phalanges, the cutaneous
fusion to the 3rd–4th phalanges, as well as a transversal mesial
phalanx of the 3rd ray in the right foot (Figure 1F). CT scanning
and reconstruction of his craniofacial bones showed the hard
palate and alveolar bone defects that are often seen in bilateral
cleft lip and palate patients (Figures 1G, 1H).
Mutation Screening
All exons and exon/intron splice junctions of the TP63 gene
were PCR-amplified as described previously [33]. PCR products
were purified with DNA Fragment Quick Purification Kit
(DingGuo, Beijing, China) and sequenced (ABI 377 Sequencer,
Figure 3. TP63 mutation and DBD structure. (A) A missense mutation K193E of p63 DBD in the proband with heterozygous A/G at nucleotide
577. (B) Sequence of exon 5 in normal control. (C) Multiple sequence alignment. K193 of human p63, indicated by the arrow, is evolutionarily
conserved as shown in four representative species. Start position of each amino acid sequence is labeled. (D) Location of K193 (shown in blue stick) is
located on the protein surface and at the loop L2-A in the crystal structure of p63 DBD monomer (shown in green ribbons, subunit D of PDB 3QYM).
(E) K193 (shown in blue space-filling models) is located in the dimer-dimer interface of the type II tetramer (subunits C, D, E, and F of PDB 3QYM).
Different subunits are shown as ribbon diagrams in different colors. Mutation of K193 will potentially affect the formation of the type II tetramer.
doi:10.1371/journal.pone.0035337.g003
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were identified by MegAlign 5.01 (DNASTAR, Madison, USA)
and confirmed by additional PCR samples and sequencing.
Protein modeling was conducted based on the recent data of p63
DBD structure in Protein Data Bank (PDB ID codes 3QYM and
3QYN, http://www.pdb.org), and mutation-related residues were
positioned in 3D structural models using PyMOL Molecular
Graphics System, Version 1.3r1.
Supporting Information
Figure S1 Hands/feet manifestation in additional pa-
tients. (A) Patient II-9 showed symmetrical deformities. His index
and middle fingers and 2nd–3rd toes were absent. The finger nails
were dystrophic. (B) Patient III-3 showed the absence of index and
middle fingers, syndactyly of 1st–2nd and 3rd–4th toes of right
foot, and the absence of 2nd toe and syndactyly of 3rd–4th toes in
her left foot. (C) Patient IV-4 showed asymmetric split hands:
missed middle finger of the right hand and syndactyly of the 3rd–
4th fingers of left hand. But absence of 2nd–3rd toes was found in
both feet. (D) Minor deformity. Patient I-2 only showed a small
split in index finger of right hand and syndactyly of 2nd–4th toes
in right foot. (E) Patient IV-2 only showed polydactyly or
syndactyly of 2nd–3rd and 4th–5th toes in right foot. No
deformity were found in both hands and left foot.
(TIF)
Figure S2 Locations of mutated residues in DBD. (A)
Residue K193, K194 and R280 and their associations with L2-A
loop of p63 DBD monomer. Side chains of residue K193, K194,
and R280 are shown in blue sticks. Hydrogen bonding interactions
of K193-E302 and R280-E200 were indicated by red dashed lines.
Structure of p63 DBD is shown in green ribbons. L2-A loop is
highlighted in red. (B) Residue G310 and T154, shown in light
blue space-filling models, are close to each other in 3D structure
and close to the bound DNA (shown in golden yellow stick model).
The subunit C, D, E, and F are shown in different colored ribbons
form type II tetramer in the crystal structure.
(TIF)
Table S1 General information of nine patients in this
study.
(DOC)
Table S2 Head and oral-craniofacial phenotypes of nine
patients.
(DOC)
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